Best Practices for an Aesthetic Neurotoxin Approach
Treating Moderate-to-Severe Plaque Psoriasis in Patients 50+ Including the Medicare Population
Treating Psoriatic Arthritis (PsA) and Ankylosing Spondylitis (AS): A Virtual Simulation
Expert Perspectives on a Treatment for Plaque Psoriasis